Hamamatsu Pharma Research (HPR) is a preclinical CRO specializing in efficacy testing using non-human primate disease models. HPR provides preclinical proof of concept studies to facilitate your go/no-go decision making for your drug development.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
nonhuman primate disease models
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):